Adopting an orphan drug: rufinamide for Lennox-Gastaut syndrome
- PMID: 19471615
- PMCID: PMC2685884
- DOI: 10.1111/j.1535-7511.2009.01298.x
Adopting an orphan drug: rufinamide for Lennox-Gastaut syndrome
Comment on
-
Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome.Neurology. 2008 May 20;70(21):1950-8. doi: 10.1212/01.wnl.0000303813.95800.0d. Epub 2008 Apr 9. Neurology. 2008. PMID: 18401024 Clinical Trial.
References
-
- Arzimanoglou A, French J, Blume WT, Cross JH, Ernst JP, Feucht M, Genton P, Guerrini R, Kluger G, Pellock JM, Perucca E, Wheless JW. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol. 2009;8:82–93. - PubMed
-
- Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord. 2007;9:353–412. - PubMed
-
- Wheless JW, Clarke DF, Carpenter D. Treatment of pediatric epilepsy: expert opinion, 2005. J Child Neurol. 2005;20(suppl 1):S1–56. - PubMed
-
- Hancock E, Cross H. Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev. 2003:CD003277. - PubMed
Publication types
LinkOut - more resources
Full Text Sources